1. Home
  2. BHST vs THTX Comparison

BHST vs THTX Comparison

Compare BHST & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHST
  • THTX
  • Stock Information
  • Founded
  • BHST 2007
  • THTX 1993
  • Country
  • BHST Canada
  • THTX Canada
  • Employees
  • BHST N/A
  • THTX N/A
  • Industry
  • BHST
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHST
  • THTX Health Care
  • Exchange
  • BHST Nasdaq
  • THTX Nasdaq
  • Market Cap
  • BHST 106.0M
  • THTX 118.2M
  • IPO Year
  • BHST N/A
  • THTX N/A
  • Fundamental
  • Price
  • BHST $6.44
  • THTX $2.62
  • Analyst Decision
  • BHST Strong Buy
  • THTX Hold
  • Analyst Count
  • BHST 2
  • THTX 1
  • Target Price
  • BHST $13.00
  • THTX N/A
  • AVG Volume (30 Days)
  • BHST 43.5K
  • THTX 6.2M
  • Earning Date
  • BHST 05-15-2025
  • THTX 04-09-2025
  • Dividend Yield
  • BHST N/A
  • THTX N/A
  • EPS Growth
  • BHST N/A
  • THTX N/A
  • EPS
  • BHST N/A
  • THTX N/A
  • Revenue
  • BHST $25,188,000.00
  • THTX $88,666,000.00
  • Revenue This Year
  • BHST $116.40
  • THTX N/A
  • Revenue Next Year
  • BHST $55.91
  • THTX $15.13
  • P/E Ratio
  • BHST N/A
  • THTX N/A
  • Revenue Growth
  • BHST 98.77
  • THTX 13.52
  • 52 Week Low
  • BHST $0.00
  • THTX $1.08
  • 52 Week High
  • BHST $7.38
  • THTX $3.13
  • Technical
  • Relative Strength Index (RSI)
  • BHST N/A
  • THTX 57.56
  • Support Level
  • BHST N/A
  • THTX $2.64
  • Resistance Level
  • BHST N/A
  • THTX $2.82
  • Average True Range (ATR)
  • BHST 0.00
  • THTX 0.17
  • MACD
  • BHST 0.00
  • THTX -0.04
  • Stochastic Oscillator
  • BHST 0.00
  • THTX 20.45

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: